Biochem Biophys Res Commun 2011, 416:409–415.PubMedCrossRef 17. Arts IC, Coolen EJ, Bours MJ, Huyghebaert N, Stuart MA, Bast A, Dagnelie PC: Adenosine 5′ -triphosphate (ATP) GANT61 molecular weight supplements are not orally bioavailable: a randomized, placebocontrolled cross-over trial in healthy humans. J Int Soc Sports Nutr 2012, 9:16.PubMedCrossRef
18. Coolen EJ, Arts IC, Bekers O, Vervaet C, Bast A, Dagnelie PC: Oral bioavailability of ATP after prolonged administration. Br J Nutr 2011, 105:357–366.PubMedCrossRef 19. Synnestvedt K, Furuta GT, Comerford KM, Louis N, Karhausen J, Eltzschig selleck HK, Hansen KR, Thompson LF, Colgan SP: Ecto-5′-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J Clin Invest 2002, 110:993–1002.PubMed 20. Calbet JA, Lundby C, Sander M, Robach P, Saltin B, Boushel R: Effects of ATP-induced leg vasodilation on VO2 peak and leg O2 extraction during maximal exercise in humans. Am J Physiol Regul Integr
Comp Physiol 2006, 291:R447-R453.PubMedCrossRef 21. Jordan AN, Jurca R, Abraham EH, Salikhova A, Mann JK, Morss GM, Church TS, Lucia A, Earnest CP: Effects of oral ATP supplementation on anaerobic power and muscular strength. Med Sci Sports Exerc 2004, 36:983–990.PubMedCrossRef 22. Bangsbo J, Krustrup P, Gonzalez-Alonso J, Saltin B: ATP production and efficiency of human skeletal muscle during intense AZD5153 manufacturer exercise: effect of previous exercise. Am J Physiol Endocrinol Metab 2001, 280:E956-E964.PubMed 23. Juel C: Lactate-proton cotransport in skeletal muscle. Physiol Rev 1997, 77:321–358.PubMed 24. Conley KE, Kemper WF, Crowther GJ: Limits to sustainable muscle performance: interaction between glycolysis and oxidative phosphorylation. J Exp Biol 2001, 204:3189–3194.PubMed 25. Sprague RS, Bowles EA, Achilleus D, Ellsworth ML: Erythrocytes as controllers of
perfusion distribution in the microvasculature of skeletal muscle. Acta Physiol (Oxf) 2011, 202:285–292.CrossRef 26. Gonzalez-Alonso J, Olsen DB, Saltin B: Erythrocyte and the regulation of human skeletal muscle blood flow and oxygen delivery: role of circulating ATP. Circ Res 2002, (-)-p-Bromotetramisole Oxalate 91:1046–1055.PubMedCrossRef 27. Bannwarth B, Allaert FA, Avouac B, Rossignol M, Rozenberg S, Valat JP: A randomized, double-blind, placebo controlled triphosphate in study of oral adenosine subacute low back pain. J Rheumatol 2005, 32:1114–1117.PubMed 28. Rossignol M, Allaert FA, Rozenberg S, Valat JP, Avouac B, Peres G, Le Teuff G, Bannwarth B: Measuring the contribution of pharmacological treatment to advice to stay active in patients with subacute low-back pain: a randomised controlled trial. Pharmacoepidemiol Drug Saf 2005, 14:861–867.PubMedCrossRef 29. Swennen EL, Coolen EJ, Arts IC, Bast A, Dagnelie PC: Time-dependent effects of ATP and its degradation products on inflammatory markers in human blood ex vivo.